Lv11
30 积分 2024-11-27 加入
Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: lessons from preclinical studies
1小时前
已完结
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
2小时前
已完结
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis
2小时前
已完结
皖公网安备34019202002308
